MANFRINATO, Maria Cristina
 Distribuzione geografica
Continente #
NA - Nord America 3.737
EU - Europa 1.196
AS - Asia 934
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 6
OC - Oceania 5
SA - Sud America 1
Totale 5.887
Nazione #
US - Stati Uniti d'America 3.724
CN - Cina 489
UA - Ucraina 295
IT - Italia 241
SG - Singapore 204
DE - Germania 181
TR - Turchia 143
GB - Regno Unito 134
PL - Polonia 89
FI - Finlandia 80
SE - Svezia 68
HK - Hong Kong 31
BE - Belgio 21
ID - Indonesia 21
CZ - Repubblica Ceca 19
FR - Francia 17
NL - Olanda 14
CA - Canada 11
IR - Iran 10
VN - Vietnam 9
ES - Italia 7
MY - Malesia 7
RO - Romania 6
SD - Sudan 6
IQ - Iraq 5
KR - Corea 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EU - Europa 4
IE - Irlanda 4
AU - Australia 3
IN - India 3
LT - Lituania 3
PT - Portogallo 3
BG - Bulgaria 2
GR - Grecia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BR - Brasile 1
GE - Georgia 1
MK - Macedonia 1
MX - Messico 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 5.887
Città #
Woodbridge 521
Fairfield 340
Jacksonville 330
Chandler 324
Houston 301
Ann Arbor 281
Ashburn 203
Singapore 157
Wilmington 139
Ferrara 119
Cambridge 113
Nanjing 110
Seattle 107
Izmir 99
Beijing 88
Princeton 81
Warsaw 76
Boardman 66
Dearborn 57
Milan 44
Shanghai 37
Nanchang 36
San Diego 33
Shenyang 32
Hong Kong 30
Changsha 28
Tianjin 25
Los Angeles 22
Brussels 21
Santa Clara 20
Bremen 19
Jakarta 19
Brno 18
Jiaxing 17
Hebei 16
Ningbo 15
Orange 15
Addison 14
Munich 14
Helsinki 13
Jinan 13
Norwalk 13
San Mateo 12
New York 11
Redwood City 11
Augusta 10
Mountain View 10
Auburn Hills 9
Dong Ket 9
Kraków 9
Washington 8
Des Moines 7
Falls Church 7
Leawood 7
Philadelphia 7
Bologna 6
Casalecchio Di Reno 6
Guangzhou 6
London 6
Montréal 6
Indiana 5
Lübeck 5
Tappahannock 5
Wageningen 5
Ardabil 4
Chicago 4
Dronten 4
Dublin 4
Düsseldorf 4
Ferrara di Monte Baldo 4
Frankfurt am Main 4
Fuzhou 4
Haikou 4
Khartoum 4
Rome 4
Shah Alam 4
Taizhou 4
Zhengzhou 4
Calderara Di Reno 3
Changchun 3
Espoo 3
Hefei 3
Kunming 3
Las Vegas 3
Paris 3
Taipei 3
Verona 3
Amsterdam 2
Chisinau 2
Dolo 2
Hsinchu 2
Kuala Lumpur 2
Lanzhou 2
Madrid 2
Melbourne 2
Ottawa 2
Sofia 2
Sulaymaniyah 2
Tehran 2
Acton 1
Totale 4.301
Nome #
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 161
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 153
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 151
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 131
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 129
null 128
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 127
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 126
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 114
null 110
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 110
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 107
null 104
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 102
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 102
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 100
null 97
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 96
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 95
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 94
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 91
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 91
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 90
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 88
null 88
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 86
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 86
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 86
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 83
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 82
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 81
Substrate binding to 6-phosphogluconate dehydrogenase 81
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 79
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 77
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 73
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 72
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 71
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 70
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 70
Mutual communication of envelope glycoproteins of paramixoviruses 70
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 70
Domain structure of the hemagglutinin-neuraminidase from sendai virus 70
Biochemical study in adult population with stroke in Ferrara, Fabry disease 70
Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high energy intermediate and transition state analogues 69
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 68
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 66
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 66
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 64
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 63
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 63
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 63
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 62
Purification of transglutaminase enzyme from L. infantum promastigotes 60
Partial unfolding of the hemagglutinin-neuraminidase from sendai virus 59
Enzymatic activation of NCX4016, a nitrate ester derivative of Aspirin 59
Xenobiotics biodegradation: recombinant DCM dehalogenase from alcaligenes xylosoxydans 57
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 57
Synthetic peptides corresponding to the heptad repeat region of sendai virus fusion protein bind to the hemagglutinin-neuraminidase 56
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 56
Unfording and limited proteolysis of the hemagglutinin-neuraminidase from sendai virus 55
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 55
Thermodynamic characterization of 6-phosphogluconate dehydrogenase ternary complex 54
null 53
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 53
Modulation of metalloproteinase-9 (MMP-9) by its specific tissue inhibitor (TIMP1) 52
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 50
null 49
inhibition of sendai virus fusion protein by interaction synthetic peptides derived F protein and hemagglutinin-neuraminidase 48
MMP-9 isoforms in serum of Multiple Sclerosis patients 47
The influence of different replacement solutions on neutrophils response 45
pH dependent structural changes of the hemagglutinin-neuraminidase from sendai virus 43
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 31
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 30
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 29
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 22
Effects of anticoagulants on the activity of gelatinases 21
Effects of anticoagulants on the activity of gelatinases 20
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases 17
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. 16
Lactoferrin administration prior to genetic amniocentesis dampens the intraamniotic inflammatory response 15
Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: beyond the pentose phosphate pathway 13
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 11
Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action 9
Influence of different strategies of volume replacement on the activity of metalloproteinases 9 9
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 8
Totale 6.005
Categoria #
all - tutte 28.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.058


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020675 0 0 0 0 54 130 103 108 84 120 55 21
2020/2021887 79 79 32 79 45 100 54 93 24 121 139 42
2021/2022639 21 70 26 21 27 25 19 25 19 71 45 270
2022/2023791 77 66 20 95 134 106 47 69 84 11 52 30
2023/2024407 42 48 16 15 61 40 10 24 17 12 8 114
2024/2025318 49 42 153 73 1 0 0 0 0 0 0 0
Totale 6.005